Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure

European Journal of Surgical Oncology

Volumn 36, Issue 7, 2010, Pages 646-651

  Derkx, F ^a   Maaskant Braat, A J G ^b   van der Sangen, M J C ^b   Nieuwenhuijzen, G A P ^b   van de Poll Franse, L V ^c,d   Roumen, R M H ^e   Voogd, A C ^a,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c Erasmus University Rotterdam and Eindhoven Cancer Registry   (Netherlands)

^d TILBURG UNIVERSITY   (Netherlands)

^e MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

Axilla; Breast carcinoma; Local recurrence; Lymph node dissection; Sentinel lymph node biopsy; Staging

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; THORAX WALL; THORAX WALL CANCER;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NETHERLANDS; REGISTRIES; SENTINEL LYMPH NODE BIOPSY; THORACIC WALL; TREATMENT OUTCOME;

EID: 77953917245     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.05.009     Document Type: Article

References (27)

1. Roumen R.M., Kuijt G.P., Liem I.H., and van Beek M.W. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 88 (2001) 1639-1643
2. Naik A.M., Fey J., Gemignani M., et al. The risk of axillary relapse after sentinel node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240 (2004) 462-468
3. Veronesi U., Paganelli G., Viale G., et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7 (2006) 983-990
4. Voogd A.C., Nielsen M., Peterse J.L., et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy of mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 15 (2001) 1688-1697
5. Jacobsen J.A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332 (1995) 907-911
6. Roumen R.M.H., Kuijt G.P., and Liem I.H. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur J Surg Oncol 32 (2006) 1076-1081
7. Port E.R., Garcia-Etienne C.A., Park J., Fey J., Borgen P.I., and Cody III H.S. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol 14 (2007) 2209-2214
8. Oncoline Oncological Guidelines. www.oncoline.nl Accessed 08.06.09
9. Voogd A.C., van Tienhoven G., Peterse H.L., et al. Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Cancer 85 (1999) 437-446
10. Giuliano A.E., Barth A.M., Spivack B., Beitsch P.D., and Evans S.W. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg 183 (1996) 262-264
11. Borner M., Bacchi M., Goldhirsch A., et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol 12 (1994) 2071-2077
12. Haylock B.J., Coppin C.M., Jackson J., Basco V.E., and Wilson K.S. Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy. Int J Radiat Oncol Biol Phys 46 (2000) 355-362
13. Rauschecker H., Clarke M., Gatzemeier, and Recht A. Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev (2001) 4
14. Aebi S, Wapnir I. A randomized clinical trial of adjuvant chemotherapy for radically resected loco-regional relapse of breast cancer. IBCSG 27-02/BIG 1-02 (BOOG 2003-02).
15. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
16. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337 (1997) 949-955
17. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year result of the British Columbia randomized trial. J Natl Cancer Inst 19 (2005) 116-126
18. Orr R.K. The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann Surg Oncol 6 (1999) 17-18
19. Martelli G., Miceli R., Costa A., et al. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study. Cancer 112 (2008) 481-488
20. Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351 (2004) 971-977
21. Wildiers H., Kunkler I., Biganzolli L., et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8 (2007) 1101-1115
22. Ververs J.M., Roumen R.M., Vingerhoets A.J., et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 37 (2001) 991-999
23. Schijven M.P., Vingerhoets A.J., Rutten H.J., et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29 (2003) 341-350
24. Karam A., Stempel M., Cody III H.S., and Port E.R. Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg 207 (2008) 543-548
25. Cox C.E., Furman B.T., Kiluk J.V., et al. Use of reoperative sentinel lymph node biopsy in breast cancer patients. J Am Coll Surg 207 (2008) 57-61
26. Intra M., Trifirò G., Galimberti V., Gentilini O., Rotmensz N., and Veronesi P. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence. Br J Surg 94 (2007) 1216-1219
27. Povoski S.P., Olsen J.O., Young D.C., et al. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel node mapping and biopsy in breast cancer. Ann Surg Oncol 13 (2006) 1412-1421